Heart Disease Trial, Recruiting NCT04046237 Sponsor: Assistance Publique - Hôpitaux de Paris Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT04046237
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been admitted to hospital for a heart attack and are already enrolled in the Frenchie registry
  • People who score 5 or higher on a screening questionnaire used to check for gum disease
  • People who have at least six teeth, not counting wisdom teeth
  • People who have signed a consent form agreeing to participate
  • People who are covered by French national health insurance (Sécurité Sociale)

Who may not be able to join:

  • People who have certain conditions known to affect gum health — such as AIDS, rheumatoid arthritis, Chediak-Higashi syndrome, or Papillon-Lefèvre syndrome — beyond heart or diabetes-related conditions
  • People who have taken a course of antibiotic tablets or injections lasting more than 48 hours within the 3 months before joining the trial
  • People who are currently experiencing acute (sudden or severe) heart failure
  • People who have uncontrolled heart rhythm problems affecting the lower chambers of the heart
  • People who would be unable to attend follow-up appointments during the trial
  • People who are unable to lie flat or reclined for 20 minutes
  • People who have been on immune-suppressing medication for more than one month within the 6 months before joining the trial
  • People who are pregnant or breastfeeding
  • People who have a known allergy or sensitivity to chlorhexidine, povidone, or 18-fluoro-deoxyglucose

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Philippe Gabriel STEG, Assistance Publique - Hôpitaux de Paris

Phone: 01 40 25 80 80

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
2 August 2019
Est. completion
1 August 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Effect of treatment of severe periodontitis in patients with an AMI

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov